NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Reclassifications) (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Research and development | $ 1,022,188 | $ 1,479,334 |
Sales and marketing | 717,809 | 950,962 |
Engineering | 1,358,925 | 1,254,235 |
AI technologies | 1,309,986 | 1,215,488 |
Administration | 5,011,913 | 3,987,941 |
Total Operating Expenses | $ 9,420,821 | 8,887,960 |
Before Reclassification [Member] | ||
Selling and marketing expenses | 421,535 | |
Salaries, wages and contract labor | 5,570,140 | |
Research and development | 431,425 | |
Professional fees | 252,825 | |
General and administrative expenses | 2,212,035 | |
Total Operating Expenses | 8,887,960 | |
After Reclassification [Member] | ||
Research and development | 1,479,334 | |
Sales and marketing | 950,962 | |
Engineering | 1,254,235 | |
AI technologies | 1,215,488 | |
Administration | 3,987,941 | |
Total Operating Expenses | $ 8,887,960 |
X | ||||||||||
- Definition Administration. No definition available.
|
X | ||||||||||
- Definition Engineering. No definition available.
|
X | ||||||||||
- Definition Sales & marketing. No definition available.
|
X | ||||||||||
- Definition The amount of expense in the period for communications and data processing expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|